Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | PTAFR | P25105 | 1/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28180682 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL27557550 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL28847899 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL27773356 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL27434430 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL28426490 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL17474391 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL3713923 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL3802705 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 | |
| SCHEMBL27534879 | 0.98 | EPHX1 (0.53) | EPHX1ALDH1A1CYP1A2TDP1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282418-A9 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | Eurofarma Laboratórios S.A. (BR) | 2024-07-17 | — | — | EP | claimed |
| EP-4282418-A1 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | Eurofarma Laboratórios S.A. (BR) | 2023-11-29 | — | — | EP | claimed |
| WO-2022178604-A1 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | EUROFARMA LABORATORIOS S.A. (BR) | 2022-09-01 | — | — | WO | claimed |
| US-20070161030-A1 | Micelle-and microemulsion-assisted planar separations platform for proteomics | PERKINELMER LAS, INC. | 2007-07-12 | — | — | US | claimed |
| WO-2007067731-A2 | MICELLE- AND MICROEMULSION-ASSISTED PLANAR SEPARATIONS PLATFORM FOR PROTEOMICS | PERKINELMER LAS, INC. (US) | 2007-06-14 | — | — | WO | claimed |
| EP-4282418-A9 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | Eurofarma Laboratórios S.A. (BR) | 2024-07-17 | — | — | EP | disclosed |
| EP-4282418-A1 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | Eurofarma Laboratórios S.A. (BR) | 2023-11-29 | — | — | EP | disclosed |
| WO-2022178604-A1 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | EUROFARMA LABORATORIOS S.A. (BR) | 2022-09-01 | — | — | WO | disclosed |
| US-20220184038-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SISAF LIMITED (GB) | 2022-06-16 | — | — | US | disclosed |
| EP-3946279-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | Sisaf Ltd (GB) | 2022-02-09 | — | — | EP | disclosed |
| WO-2020193998-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SISAF LIMITED (GB) | 2020-10-01 | — | — | WO | disclosed |
| EP-3714879-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | Sisaf Ltd (GB) | 2020-09-30 | — | — | EP | disclosed |
| EP-1913390-A2 | ASSAY PARTICLES AND METHODS OF USE | PerkinElmer LAS, Inc. (US) | 2008-04-23 | — | — | EP | disclosed |
| EP-1774276-A4 | METHODS AND COMPOSITIONS FOR DETECTING AND ISOLATING PHOSPHORYLATED MOLECULES USING HYDRATED METAL OXIDES | PERKINELMER LAS INC (US) | 2007-08-29 | — | — | EP | disclosed |
| US-20070161030-A1 | Micelle-and microemulsion-assisted planar separations platform for proteomics | PERKINELMER LAS, INC. | 2007-07-12 | — | — | US | disclosed |
| WO-2007067731-A2 | MICELLE- AND MICROEMULSION-ASSISTED PLANAR SEPARATIONS PLATFORM FOR PROTEOMICS | PERKINELMER LAS, INC. (US) | 2007-06-14 | — | — | WO | disclosed |
| EP-1774276-A2 | METHODS AND COMPOSITIONS FOR DETECTING AND ISOLATING PHOSPHORYLATED MOLECULES USING HYDRATED METAL OXIDES | Perkinelmer Las, Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
| WO-2007022074-A2 | ASSAY PARTICLES AND METHODS OF USE | PERKINELMER LAS, INC. (US) | 2007-02-22 | — | — | WO | disclosed |
| US-20070037215-A1 | Assay particles and methods of use | PERKINELMER LAS, INC. | 2007-02-15 | — | — | US | disclosed |
| WO-2006014424-A2 | METHODS AND COMPOSITIONS FOR DETECTING AND ISOLATING PHOSPHORYLATED MOLECULES USING HYDRATED METAL OXIDES | PERKINELMER LAS, INC. (US) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220184038-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SGMS1, SGMS2, SMURF1 | EPHX1 1527/4885ALDH1A1 4855/4885CYP1A2 3857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.